C
FENC icon

Covestor’s Fennec Pharmaceuticals FENC Stock Holding History

Covestor’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-77
Closed – – 2381
2024
Q2 		$0 Buy
+77
New +$639 ﹤0.01% 2397

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

Covestor's FENC Position: Q3 2024 in Review

Covestor sold out of Fennec Pharmaceuticals (FENC) in Q3 2024, closing a stake of 77 shares.

Covestor first reported a position in FENC in Q2 2024 and held it in 1 quarter. The position peaked at $0 in Q2 2024. 63 funds tracked by Wall St. Rank hold FENC as of Q3 2024.

  • Covestor reported no remaining Fennec Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Covestor sold 77 Fennec Pharmaceuticals shares in Q3 2024.
  • Covestor first reported a position in Fennec Pharmaceuticals in Q2 2024 and held it in 1 quarter.
  • Covestor's Fennec Pharmaceuticals position peaked at $0 in Q2 2024.
  • 63 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2024.

Based on Covestor's 13F filing for Q3 2024, filed 1 Nov 2024.